Skip to content

Examination of suppression effects of a Lactic acid bacteria EF2001 on Candida fungus

Examination of suppression effects of a Lactic acid bacteria EF2001 on Candida fungus - Suppression effect of EF2001 on Candida fungus

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000033035
Enrollment
10
Registered
2018-06-30
Start date
2017-05-22
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral candidiasis

Interventions

Intake powdery test food containing 75 billion lactic acid bacteria (EF 2001) with water or lukewarm water before sleeping once a day,and continue for 1 week.

Sponsors

KANEROKU Pharmaceutical Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Those who tend to have less salivation. (2) Adult males and females aged 40 to 80 at the time of acquisition. (3) A person who received the explanation of the relevant clinical trial in advance, can understand its contents, obtains document consent by the person himself / herself.

Exclusion criteria

Exclusion criteria: (1) Those who are ongoing treatment with drugs. (2) Those who routinely consume medicines, foods for specified health use, health foods, functional display foods, etc. that are likely to affect the test results. (3) Person who has a history of severe disease (cancer etc) and history of current in heart, liver, kidney, gastrointestinal etc. (4) Those during pregnancy, breast-feeding during the study period, or those who wish for pregnancy during the period. (5) Persons whose eating habits are extremely irregular, such as shift workers or late night workers whose life rhythms are irregular. (6) Persons who are allergic to pharmaceuticals and foods (especially test foods). (7) Participating in clinical trials of other medicinal products or health foods, those within 4 weeks after the examination or those who intend to participate in other clinical trials after participating in the study. (8) Who are judged inappropriate to participate in the exam by the investigator dentist or a sub investigator dentist.

Design outcomes

Primary

MeasureTime frame
[Before administration and one week after starting administration] Candida bacteria test

Secondary

MeasureTime frame
[ Before administration ] Background survey : gender / date of birth / age / past history / complications, drugs used, regular specified health food, health food, functional display food etc. [Before administration and one week after starting administration] Saliva quantity test Questionnaire on subjective symptoms

Countries

Japan

Contacts

Public ContactSaito Ichiro

Tsurumi-University School of Dental Medicine Department of Pathology

saito-i@tsurumi-u.ac.jp+81-45-580-8360

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026